Kuano Company
Kuano provides innovative quantum and AI solutions for drug discovery and design.
Investors
Technology:
Artificial Intelligence, Biotechnology
Industry:
AI, Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2020-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
4
Total Funding:
1000000
Last Funding Date:
2021-07-08
Last Funding Type:
Seed
Register and Claim Ownership